These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2363276)

  • 21. Differentiation between two African arenaviruses (Lassa and Mozambique) by plaque assay.
    Tomori O; Johnson K
    Acta Virol; 1987 Mar; 31(2):146-51. PubMed ID: 2886023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological survey for the detection of antibodies to lassa virus in India.
    Rodrigues FM; Gupta NP; Pinto BD
    J Indian Med Assoc; 1978 Jan; 70(2):25-8. PubMed ID: 659905
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunogenic and protective characteristics of recombinant Lassa virus NP protein].
    Ignat'ev GM
    Vopr Virusol; 2002; 47(2):28-31. PubMed ID: 12046464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and use of erythrocyte-globulin conjugates to Lassa virus in reversed passive hemagglutination and inhibition.
    Goldwasser RA; Elliott LH; Johnson KM
    J Clin Microbiol; 1980 Jun; 11(6):593-9. PubMed ID: 7000810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A trial to produce an inactivated Lassa fever vaccine].
    Krasnianskiĭ VP; Potryvaeva NV; Borisevich IV; Gradoboev VN; Pashanina TP; Pshenichnov VA
    Vopr Virusol; 1993; 38(6):276-9. PubMed ID: 8303891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Standardization of a plaque assay for Lassa virus.
    Tomori O; Johnson KM; Kiley MP; Elliott LH
    J Med Virol; 1987 May; 22(1):77-89. PubMed ID: 3585290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modifications to indirect immunofluorescence tests on Lassa, Marburg, and Ebola material.
    van der Groen G; Kurata T; Mets C
    Lancet; 1983 Mar; 1(8325):654. PubMed ID: 6131336
    [No Abstract]   [Full Text] [Related]  

  • 28. Evolutionary biology of a Lassa virus complex.
    Gonzalez JP; Georges AJ; Kiley MP; Meunier DM; Peters CJ; McCormick JB
    Med Microbiol Immunol; 1986; 175(2-3):157-9. PubMed ID: 3724662
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of Ippy as a Lassa-fever-related virus.
    Swanepoel R; Leman PA; Shepherd AJ; Shepherd SP; Kiley MP; McCormick JB
    Lancet; 1985 Mar; 1(8429):639. PubMed ID: 2857974
    [No Abstract]   [Full Text] [Related]  

  • 30. Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies.
    Ruo SL; Mitchell SW; Kiley MP; Roumillat LF; Fisher-Hoch SP; McCormick JB
    J Gen Virol; 1991 Mar; 72 ( Pt 3)():549-55. PubMed ID: 1706408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the Lassa virus nucleocapsid protein in insect cells infected with a recombinant baculovirus: application to diagnostic assays for Lassa virus infection.
    Barber GN; Clegg JC; Lloyd G
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():19-28. PubMed ID: 2406367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serology and virulence diversity among Old-World arenaviruses, and the relevance to vaccine development.
    Jahrling PB; Peters CJ
    Med Microbiol Immunol; 1986; 175(2-3):165-7. PubMed ID: 3724664
    [No Abstract]   [Full Text] [Related]  

  • 33. Lassa virus antibodies in hospital personnel in western Liberia.
    Frame JD; Casals J; Dennis EA
    Trans R Soc Trop Med Hyg; 1979; 73(2):219-24. PubMed ID: 382467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indirect solid-phase immunosorbent assay for detection of arenavirus antigens and antibodies.
    Ivanov AP; Rezapkin GV; Dzagurova TK; Tkachenko EA
    Acta Virol; 1984 May; 28(3):240-5. PubMed ID: 6148001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lassa fever virus: properties and characteristics.
    Tomori O; Fabiyi A
    Niger Med J; 1979 Jan; 9(1):17-9. PubMed ID: 111436
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lassa virus and myeloid dendritic cells: a privileged tropism for the suppression of the T lymphocyte response].
    Baize S
    Med Sci (Paris); 2019; 35(8-9):619-621. PubMed ID: 31532370
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of immunosuppression on the development and outcome of an acute infection in mice caused by administration of the Lassa virus].
    Barkar ND; Mar'iankova RF; Godneva AT; Grigor'eva LV; Zudin BI
    Vopr Virusol; 1989; 34(2):208-13. PubMed ID: 2763513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The isolation and characteristics of recombinant monoclonal antibodies to the Lassa virus].
    Vladyko AS; Kunitskaia LIa; Bystrova SI; Kras'ko AG; Lemeshko NN; Lukashevich IS
    Vopr Virusol; 1990; 35(5):396-8. PubMed ID: 2267781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lassa and Mozambique viruses: cross protection in experiments on mice and action of immunosuppressants on experimental infections].
    Barkar ND; Lukashevich IS
    Vopr Virusol; 1989; 34(5):598-603. PubMed ID: 2609647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.